A multifactor authentication link is now sent to users to verify identify upon log in. The link is valid only 20 mins. It may be clicked or copied and pasted into the url address bar of the browser.

Europe/Zurich English Login

Defining pretomanid critical concentration (CC) for phenotypic drug-susceptibility testing (DST) methods

1–2 Dec 2022
Geneva International Conference Centre (CICG)
Europe/Zurich timezone

Administrative Support: Lou Maureen Comia

Meeting objective:

To review evidence (published and unpublished) on minimal inhibitory concentrations (MICs) to determine the ECOFF(s), assess the association of the ECOFF(s) with clinical outcome data (where available) and lineage in order to define pretomanid CC for MGIT, 7H10, 7H11, LJ methods.

Starts
Ends
Europe/Zurich
In-Person
Geneva International Conference Centre (CICG), Geneva, Switzerland
17 rue de Varembe 1211 Geneva
Concept note.docx
Registration
Registration for this event is currently open.
Media Accreditation
Accreditation requests for this event is currently open.
Powered by Indico / Brought to you by UNOG and